Creating new tools to analyze gene activity in tissue samples
Developing new computational tools for spatial transcriptomics data
This study is working on new ways to look at how genes behave in tissue samples, which can help us understand diseases like cancer better, and it aims to create tools that make it easier to analyze this information so that patients can receive better diagnoses and treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10880570 on NIH RePORTER |
What this research studies
This research focuses on advancing spatial transcriptomics, a technology that measures gene activity in tissue samples while mapping its location. The project aims to develop computational tools that can overcome current challenges in analyzing this complex data, which is crucial for understanding diseases like cancer. By creating methods to identify genes with specific spatial expression patterns and analyze data from multiple samples, the research seeks to enhance our biological insights. Patients may benefit from improved diagnostic and treatment strategies as a result of these advancements.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with breast cancer or other cancers where spatial transcriptomics could provide valuable insights.
Not a fit: Patients with conditions unrelated to cancer or those not requiring spatial transcriptomic analysis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for patients with cancers and other diseases.
How similar studies have performed: Other research has shown promise in using computational tools for analyzing complex biological data, indicating potential success for this approach.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Chen, Mengjie — University of Chicago
- Study coordinator: Chen, Mengjie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.